Optimizing Outcomes When Using Biologics for Treatment of Psoriasis

Experts discuss the plethora of treatment options for psoriasis, including topicals, oral therapies, phototherapy, and biologics.

Dermatologist and rheumatologist Saakshi Khattri highlights the importance of screening psoriasis patients for psoriatic arthritis and how that may impact treatment decisions.

Experts discuss the use of TNF blockers in treating plaque psoriasis and their limited but important uses today.

Experts discuss the landscape of IL therapies for the treatment of psoriasis, highlighting their improved safety and efficacy over prior agents.

Experts discuss common comorbidities for patients with plaque psoriasis and how they can impact treatment decisions.

Experts highlight how a history of cancer may impact psoriasis treatment decisions while touching on the safety profiles of newer IL agents.

Experts emphasize the importance of collaboration with infectious disease specialists for patients with tuberculosis, while highlighting the low reactivation rates in newer agents.

Experts discuss the warnings regarding IL-17 blockers and inflammatory bowel disease.

Experts discuss bimekizumab for the treatment of psoriasis highlighting is efficacy over other treatments.

Experts discuss package warnings associated with bimekizumab and how they inform patients of them.

Experts conclude the series discussing how to approach switching psoriasis treatments.